Valeant Pharmaceuticals International Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (68)

Latest Posts

About This Stock More About This Stock
Summer Sitting
Article By: Warren Bevan
Tuesday, August 8, 2017 10:48 PM EDT
The stock action is what you’d expect in August, choppy, with no direction. A few trades here and there may pop up but mostly cash seems to be best to me still.
In this article: VRX, SPY
Read
Valeant Pharmaceuticals Q2 2017 Earnings Boost Share Price
Article By: ValueWalk
Tuesday, August 8, 2017 9:00 AM EDT
The drug maker reported adjusted earnings of $1.05 per share on $2.23 billion in revenue. Valeant said the year-over-year decline in revenues was due to lower volumes and prices in its U.S. Diversified Products segment.
In this article: VRX
Read
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Article By: Arpita Dutt
Monday, July 17, 2017 11:35 AM EDT
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read
After The Towel Is Thrown
Article By: Tim Knight
Thursday, July 13, 2017 8:53 PM EDT
Bill Ackman had a famously bad time with Valeant Pharmaceuticals, which crashed from $263 to the single digits. Stock is up about 60% from where the Ackman capitulation took place, showing that even billionaires can make really regrettable decisions.
In this article: VRX
Read
Daily Fishing Video For Monday, June 26: FAANG Fall-Out
Video By: Samantha LaDuc
Monday, June 26, 2017 11:16 PM EDT
I’m staying short Tech despite end-of-quarter markup and here’s why…
In this video: AMD, APC, BA, DVN, GS, HCA, MCD, P, SVXY, THC, VRX, QQQ, AAPL, MSFT, NFLX, NVDA, TSLA, FXY, GDX, GLD, NUGT, VXX, XLE, XLF, XLV, TWTR
Watch

PARTNER HEADLINES

Latest Tweets for $VRX

No tweets yet!